VAR2 Pharmaceuticals

Private

CopenhagenHealthcare & Life Scienceshttps://var2pharma.com/

Last Round

VC Round

Jun 15, 2022

Total Funding Raised

$4.36M

Company Overview

VAR2 Pharmaceuticals is a biotechnology company that develops first-in-class cancer therapeutics targeting oncofetal Chondroitin Sulfate.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Imaging

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyoncologyantibody-drug conjugateADCcancer therapyoncofetal chondroitin sulfateofCSclinical-stage biotechsolid tumor treatmentmedical imagingPET imagingtargeted cancer therapyprecision oncologybiologicsdrug discoveryclinical trials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VAR2 Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

VAR2 Pharmaceuticals comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VAR2 Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Jun 15, 2022
Grant	Jun 15, 2022
Grant	Jun 15, 2022
Grant	Apr 1, 2022
Grant	Jul 6, 2020
Seed	Jan 1, 2012

View all Funding Rounds

Key People

Founding team and executive leadership

Ali Salanti

CEO

Executive Team

VAR2 Pharmaceuticals Investors

Notable investors and investment history

VAR2 Pharmaceuticals investors
Investor	Rounds
Novo Nordisk Foundation	Grant
Kirsten og Freddy Johansens Fond	Grant
European Union	Grant
The University of Copenhagen	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 15, 2022
$11M raised in a VC Round.

View all signals

VAR2 Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

VAR2 Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VAR2 Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen

Employee Range8

Year Founded2012

Last FundingJun 15, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.